SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-209988
Filing Date
2021-07-07
Accepted
2021-07-07 17:18:29
Documents
5
Period of Report
2021-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d69289d8k.htm 8-K 28381
2 EX-10.1 d69289dex101.htm EX-10.1 56329
3 EX-10.2 d69289dex102.htm EX-10.2 36313
4 EX-10.3 d69289dex103.htm EX-10.3 36096
5 EX-10.4 d69289dex104.htm EX-10.4 35474
  Complete submission text file 0001193125-21-209988.txt   194052
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 211078141
SIC: 2834 Pharmaceutical Preparations